The core activity of Pharmotech SA is the research and development of medical products based on plant-based active ingredients, particularly CBD, to combat multi-resistant bacteria (MDR-MRSA). The company focuses on researching and developing innovative solutions to combat bacteria such as Pseudomonas Aeruginosa and Staphylococcus Aureus.
AI-generated
Offering
Products & services
Industry:Research & DevelopmentPharmaceutical Industry
Outbound Leads by COHAGA
Looking for direct email addresses and phone numbers?
Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.
Research and development on CBD as an antibacterial agent against Pseudomonas aeruginosa, Staphylococcus aureus and other MDR-MRSA bacteria; proof-of-concept studies, clinical trials and patent development.
Hand Sanitizer (PSEUDOMA®)
Hydroalcoholic hand disinfectant for private and professional use; 250 ml bottle, planned 500 ml and 5 L formats, with CBD, ethanol-based and patented.
Pseudomonas aeruginosa Solutions
Solutions against Pseudomonas aeruginosa using CBD-based approaches; focus on prevention and treatment, decontamination of medical materials and hospital rooms, plus hospital and veterinary applications.
Knowledge
No knowledge articles yet
Once Pharmotech SA has claimed this profile, we'll publish editorial articles and case studies here together.